Lee Pharmaceuticals
(OTC) LPHM
This security has been delisted. This page is retained for historical reference.
LPHM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowLPHM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-70%
Return on Capital
-9%
Return on Assets
-17%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$3.03M
Operating Income
$874.00K
EBITDA
-$934.00K
Operating Cash Flow
-$897.00K
Capital Expenditure
-$373.00K
Free Cash Flow
-$1.27M
Cash & ST Invst.
$28.00K
Total Debt
$7.60M
Lee Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.23M
+33.0%
Gross Profit
$966.00K
+37.8%
Gross Margin
43.24%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
1
N/A
Net Income
$1.00K
+100.2%
EBITDA
$272.00K
+144.7%
Quarterly Fundamentals
Net Cash
-$7.05M
-3.1%
Accounts Receivable
$659.00K
+163.6%
Inventory
$2.16M
-19.1%
Long Term Debt
$1.53M
-43.7%
Short Term Debt
$5.54M
+34.1%
Return on Assets
-17.24%
N/A
Return on Invested Capital
-8.73%
N/A
Free Cash Flow
$136.00K
+149.6%
Operating Cash Flow
$210.00K
+208.2%